Recent Updates
Recently added Catalysts
BMRA Positive Sentiment Score: 70/100

Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16

Friday, November 10, 2023 1 min read
Key Takeaway: Biomerica, Inc. has announced its participation in the 14th Annual Craig-Hallum Alpha Select Conference scheduled for November 16, 2023. The conference will take place at the Sheraton New York Times Square Hotel, where CEO Zackary Irani will host various meetings. This engagement underscores Biomerica's commitment to advancing its biomedical technology and enhancing stakeholder relations. The company specializes in diagnostic and therapeutic products, particularly in the gastrointestinal and inflammatory disease sectors.

Market Sentiment Analysis

POSITIVE FACTORS

  • Biomerica is actively participating in an important industry conference.
  • The event may lead to valuable networking opportunities for the company.
  • CEO Zackary Irani is engaging directly with investors and stakeholders.

Full Press Release Details

IRVINE, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products today announced that it will participate in the 14th Annual Craig-Hallum Alpha Select Conference on November 16, 2023, at the Sheraton New York Times Square Hotel in New York City. Zackary Irani, Chief Executive Officer of Biomerica will be hosting meetings during the event, which consists of one-on-one and small group meetings.
About Biomerica (NASDAQ: BMRA)
Biomerica, Inc. (www.biomerica.com) is a global biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians' offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. The Company's products are designed to enhance the health and well-being of people, while reducing total healthcare costs. Biomerica is primarily focused on gastrointestinal and inflammatory diseases where the Company has multiple diagnostic and therapeutic products in development.
investors@biomerica.com
Source: Biomerica, Inc.

Tags

Irritable Bowel Syndrome
Nee treatment for IBS
New personalized IBS therapy

Frequently Asked Questions

When will Biomerica participate in the Craig-Hallum Conference?

Biomerica will attend the Craig-Hallum Alpha Select Conference on November 16, 2023.

Who will represent Biomerica at the conference?

Zackary Irani, the CEO of Biomerica, will host meetings at the event.

What does Biomerica specialize in?

Biomerica develops diagnostic and therapeutic products for gastrointestinal diseases.

Where is the Craig-Hallum Conference held?

The conference takes place at the Sheraton New York Times Square Hotel.

What is Biomerica's focus in healthcare?

Biomerica aims to enhance health while reducing overall healthcare costs.

Tags: BMRA Viatris Investor Conferences Healthcare Biomerica investor conference Craig-Hallum diagnostic products
Last updated: Nov 10, 2023